Diaporine Potentiates the Anticancer Effects of Oxaliplatin and Doxorubicin on Liver Cancer Cells
Recent studies have shown that diaporine, a novel fungal metabolic product, has a strong in vitro and in vivo anticancer effect on human non-small-cell lung and breast cancers. In this study, three human hepatocarcinoma cell lines (HepG2, Hep3B, and Huh7) were used to evaluate the efficacy of diapor...
Main Authors: | Shiliu Tian, Rui Su, Ke Wu, Xuhan Zhou, Jaydutt V. Vadgama, Yong Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/12/8/1318 |
Similar Items
-
WD repeat domain 62 (WDR62) promotes resistance of colorectal cancer to oxaliplatin through modulating mitogen-activated protein kinase (MAPK) signaling
by: Juanjuan Cai, et al.
Published: (2022-06-01) -
Oxaliplatin combined with daunorubicin induces apoptosis of colon cancer cell line HT-29
by: TIAN Chun-yang, LIU Xiao-zheng, FAN Jun-chao
Published: (2020-03-01) -
Prediction for oxaliplatin‐induced liver injury using patient‐derived liver organoids
by: Kumiko Tatsumi, et al.
Published: (2024-02-01) -
A rare case of localized peliosis hepatis during adjuvant chemotherapy including oxaliplatin mimicking a liver metastasis of colon cancer
by: Akira Dejima, et al.
Published: (2023-11-01) -
Anticancer Potential of Pyridoxine-Based Doxorubicin Derivatives: An In Vitro Study
by: Rawdah Karwt, et al.
Published: (2024-02-01)